Linear Clinical Research, an Australian clinical research company based in Perth has announced a trial for a potential Covid-19 vaccine. The company said it will be seeking both healthy volunteers to test the vaccine within the next two months.
According to reports, the vaccine is a “ground-breaking” potential vaccine being developed to help the body produce antibodies to fight the coronavirus.
The report confirms that a China-based Biotechnology Company, Clover Biopharmaceuticals is the original creator of the vaccine. The Chinese company developed the potential Covid-19 vaccine called ‘COVID-19 S-Trimer’.
In an official statement released Tuesday, shows that both companies have worked hand-in-hand in creating the vaccines, which the Australian outfit happened to have gotten clearance from its authorities to begin human tests in the country.
Making the announcement, chief executive of Linear Clinical Research Company, Jayden Rogers said the vaccine showed great potential and securing the trial was a major coup for Australia.
“This is one of the most prominent trials globally and involves some of the most renowned vaccines companies,” Mr. Rogers said in the statement.
He added that Clover Biopharmaceuticals based in China was one of the first companies to start developing a vaccine when it began work in January.
“COVID-19 S-Trimer is one of the first potential vaccines to make it to human trials”, he said.
The report further added that Linear Clinical Research will be seeking healthy adults, including the elderly, to volunteer for the first phase of the trial within the next two months.
“We are fortunate to be one of the few countries in the world to still be offering functional clinical trial facilities because we do not have large volumes of COVID-19 cases as compared to other parts of the world,” Mr. Rogers said.
If proved successful, the next phase of the trial would involve thousands of people around the world. Experts say this will only be possible if other countries will welcome the tests in their regions, adding that carrying tests in different regions will help determine the viability of the vaccine.
Many observers have opined that the next phase of testing should be carried out in Africa as the world continues to wait on the World Health Organization (WHO) for headways. The organization had earlier stated that a vaccine was about a dozen months away.
The suggestion to carry out the second phase of tests of the COVID-19 S-Trimer in Africa has sparked reactions, placing critics on either side of a divide.
Some critics argue that the suggestion that Africa should be a testing ground for vaccines is only a reflection of how the international community perceives the continent. They claim that Africa should not accept the tag of ‘testing-ground’, nor should Africans accept to be ‘lab rats’.
However, other critics claim that the obvious option to test vaccines in Africa is as a result of DNA composition and immunity. Speaking to TAE via an email interview on the subject matter, a renowned social commentator and Journalist from Nigeria, who pleaded anonymity, said he sees nothing wrong with the testing since the vaccines will also be tested in other parts of the world.
“This vaccine has been tested on some foreigners, but it must be tested on Africans to know if it is valid; not because we are lab rats like some people claim, but because we are seen as a stringer specie. One way or the other, vaccines must be tested”, he said.
What are your thoughts? Do you think Africans should volunteer for the second phase of testing for the COVID-19 S-Trimer?